These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37510899)

  • 1. COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective.
    Cioboata R; Biciusca V; Olteanu M; Vasile CM
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.
    Luke E; Swafford K; Shirazi G; Venketaraman V
    Front Biosci (Schol Ed); 2022 Mar; 14(1):6. PubMed ID: 35320917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa.
    Loveday M; Cox H; Evans D; Furin J; Ndjeka N; Osman M; Naidoo For The National Tb Think Tank 'Optimising Tb Treatment Outcomes' Task Team K
    S Afr Med J; 2020 Nov; 110(12):1160-1167. PubMed ID: 33403958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
    Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Bostanghadiri N; Jazi FM; Razavi S; Fattorini L; Darban-Sarokhalil D
    Front Microbiol; 2021; 12():747827. PubMed ID: 35185809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do?
    Abdulgader SM; Okunola AO; Ndlangalavu G; Reeve BWP; Allwood BW; Koegelenberg CFN; Warren RM; Theron G
    Respiration; 2022; 101(9):797-813. PubMed ID: 35760050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis and COVID-19: A combined global threat to human civilization.
    Patra K; Batabyal S; Mandal K; Ghose D; Sarkar J
    Clin Epidemiol Glob Health; 2022; 15():101031. PubMed ID: 35372717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic methods in the COVID-19 pandemic, today and in the future.
    Wu SY; Yau HS; Yu MY; Tsang HF; Chan LWC; Cho WCS; Shing Yu AC; Yuen Yim AK; Li MJW; Wong YKE; Pei XM; Cesar Wong SC
    Expert Rev Mol Diagn; 2020 Sep; 20(9):985-993. PubMed ID: 32845192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India.
    Hazra D; Chawla K; Shenoy VP; Pandey AK; S N
    J Infect Public Health; 2021 Aug; 14(8):1095-1098. PubMed ID: 34274858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal.
    Singh A; Prasad R; Gupta A; Das K; Gupta N
    Monaldi Arch Chest Dis; 2020 Jul; 90(3):. PubMed ID: 32697060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum Samples.
    Barbosa-Amezcua M; Cuevas-Córdoba B; Fresno C; Haase-Hernández JI; Carrillo-Sánchez K; Mata-Rocha M; Muñoz-Torrico M; Bäcker C; González-Covarrubias V; Alaez-Verson C; Soberón X
    Microbiol Spectr; 2022 Oct; 10(5):e0125222. PubMed ID: 36102651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upstaging of Tuberculosis in the Post-COVID-19 Era: A Case Series.
    Malik N; Sidhar M; Sehgal NP; Gupta A; Gupta I
    Cureus; 2024 Feb; 16(2):e54687. PubMed ID: 38524066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection.
    Ata F; Shaher Mousa Hussein M; Mismar AY; Sharma R; Bozom IAM; Alsiddig Ali Ibrahim Z; Ibrahim WH
    Am J Case Rep; 2020 Aug; 21():e927586. PubMed ID: 32840240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis and COVID-19: An overlapping situation during pandemic.
    Can Sarınoğlu R; Sili U; Eryuksel E; Olgun Yildizeli S; Cimsit C; Karahasan Yagci A
    J Infect Dev Ctries; 2020 Jul; 14(7):721-725. PubMed ID: 32794460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of COVID-19 on tuberculosis: challenges and opportunities.
    Kant S; Tyagi R
    Ther Adv Infect Dis; 2021; 8():20499361211016973. PubMed ID: 34178322
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.